Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA on/off controllability estimation in Parkinson's disease
NL-OMON56646Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levodopa in Parkinson's disease (PD), sponsored by Radboud University Medical Center. Primary endpoints: Behavioral estimation of controllability between study sessions and BOLD response differences related to behavioral task manipulations between study sessions. Started Feb 2025; status: recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON56646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56646.